Nicotinamide mononucleotide adenylyltransferase promotes hypoxic survival by activating the mitochondrial unfolded protein response

Keyphrases

• Nicotinamide Mononucleotide Adenylyltransferase (NMNAT) 100%
• Mitochondrial Unfolded Protein Response 100%
• Caenorhabditis Elegans 27%
• Taxol 27%
• Gain-of-function mutation 18%
• Axonal Degeneration 18%
• Hypoxia 18%
• Cytoprotection 18%
• Loss Function 9%
• Mutated Genes 9%
• Axonal Injury 9%
• Axonal Pathology 9%
• Ethidium Bromide 9%
• Responsive Genes 9%
• Nematode Caenorhabditis Elegans 9%
• Chemotherapy Drugs 9%
• Transcriptional Reporter 9%
• Response Factor 9%
• Non-nuclear 9%
• Anoxic Brain Injury 9%
• Hypoxic Injury 9%
• Animal Death 9%
• Genetic Suppressor 9%
• Basal Expression 9%
• Mitochondrial Proteostasis 9%

Biochemistry, Genetics and Molecular Biology

• Unfolded Protein Response 100%
• Nicotinamide 100%
• Caenorhabditis Elegans 36%
• Cell Protection 18%
• Nerve Fiber Degeneration 18%
• Genetics 9%
• Lifespan 9%
• Nematode 9%
• Protein Homeostasis 9%
• Gain of Function Mutation 9%
• Response Factor 9%
• Ethidium Bromide 9%

Neuroscience

• Unfolded Protein Response 100%
• Nicotinamide Nucleotide Adenylyltransferase 100%
• Caenorhabditis Elegans 36%
• Paclitaxel 27%
• Nerve Fiber Degeneration 18%
• Axonal Degeneration 18%
• Gain of Function Mutation 9%
• Ethidium Bromide 9%